ythdc2 (Cell Signaling Technology Inc)
Structured Review
Ythdc2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 32 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ythdc2/YTHDF3+Antibody/bio_rxiv__64898__2026__03__09__710444-135-19-20
Average 94 stars, based on 32 article reviews
Images
Related Articles
other:Article Title: N6-methyladenosine modification of HCV RNA genome regulates cap-independent IRES-mediated translation via YTHDC2 recognition Article Snippet: Antibodies were obtained from the following suppliers: anti-HCV core (ab2740), anti-HCV NS5A (ab13833), and anti-FTO (sb92821) antibodies from Abcam; anti-YTHDF3 (SC-379119) and anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH; SC-47724) antibodies from Santa Cruz Biotechnology; anti-METTL3 (15073-1-AP) antibody from Proteintech Group; anti-METTL14 (HPA038002) antibody from Sigma-Aldrich; anti-La antigen (2081), anti-YTHDF1 (86463), anti-YTHDF2 (80014), anti-YTHDC2 (35440), and Article Title: N6-methyladenosine modification of the 5′ epsilon structure of the HBV pregenome RNA regulates its encapsidation by the viral core protein Article Snippet: Antibodies were obtained as follows: anti-YTHDF3 (#SC-379119), anti-preS2 (#SC-23944), and anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH; #SC-47724) antibodies from Santa Cruz Biotechnology; anti-METTL3 (#15073–1-AP) antibody from Proteintech Group; anti-METTL14 (#HPA038002) antibody from Sigma-Aldrich; anti-YTHDF1 (#86463), anti-YTHDF2 (#80014), anti-YTHDC2 (#35440), and Article Title: Fuzheng Shengbai Decoction Enhances Antitumor Immunity via YTHDC2-Dependent Stabilization of CLCA2 mRNA in Colorectal Cancer. Article Snippet: Ethnopharmacological relevance: Traditional Chinese medicine (TCM) has demonstrated multiple therapeutic advantages in colorectal cancer (CRC) management.. The herbal formula Fuzheng Shengbai Decoction (FZSB) has been widely used in clinical practice with well-documented therapeutic efficacy; nevertheless, the mechanisms underlying its anti-CRC effects remain largely unexplored.. Aim of the study: To evaluate the therapeutic efficacy of FZSB in colorectal cancer and its potential underlying mechanisms. |
